Solriamfetol-based solutions for agricultural, livestock, athletic, and cognitive applications
Legal Citation
Summary of the Inventive Concept
The inventive concept leverages the core technology of solriamfetol therapy to develop novel applications in agriculture, livestock, athletics, and cognitive enhancement, addressing unmet needs in these fields.
Background and Problem Solved
The original patent focused on solriamfetol therapy for subjects with impaired renal function, primarily targeting excessive daytime sleepiness. However, the technology's potential extends beyond this scope. The new inventive concept addresses the limitations of the original patent by exploring novel applications that capitalize on solriamfetol's benefits.
Detailed Description of the Inventive Concept
The inventive concept comprises four primary applications: (1) a system for monitoring and managing agricultural crop yields, utilizing solriamfetol to promote plant growth; (2) a method for optimizing livestock feed formulations, adjusting solriamfetol content based on renal function to enhance feed efficiency; (3) a composition for improving exercise performance in athletes, incorporating solriamfetol to enhance bioavailability in subjects with moderate renal impairment; and (4) a method for enhancing cognitive function in individuals with ADHD, administering solriamfetol in doses adapted to renal function.
Novelty and Inventive Step
The new claims introduce novel applications of solriamfetol therapy, extending its use beyond excessive daytime sleepiness and impaired renal function. The inventive concept's novelty lies in its ability to adapt solriamfetol's benefits to diverse fields, addressing unmet needs and providing innovative solutions.
Alternative Embodiments and Variations
Alternative embodiments may include integrating solriamfetol with other compounds to enhance its effects, developing targeted delivery systems for specific applications, or exploring additional industries where solriamfetol's benefits could be leveraged.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the agricultural, livestock, athletic, and cognitive enhancement industries, offering novel solutions to pressing problems and unmet needs. The market for these applications is substantial, with potential for widespread adoption and revenue growth.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical and therapeutic applications involving drug dosing, pharmacokinetics, and physiological function optimization across medical and biological domains
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced training in pharmacology, biochemistry, and therapeutic design, capable of understanding drug metabolism, renal function interactions, and cross-domain application strategies
Obviousness Rationale
The PTD demonstrates predictable extensions of the source patent's core solriamfetol technology by applying known pharmacological principles of dose adaptation and targeted delivery across multiple domains. A PHOSITA would recognize that the fundamental mechanism of renal function-based dosing can be systematically translated to different application contexts with reasonable expectation of success. The disclosed variations represent logical extrapolations of the original therapeutic approach, utilizing standard techniques of compound adaptation and targeted formulation.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,528 |
|---|---|
| Title | Methods of providing solriamfetol therapy to subjects with impaired renal function |
| Assignee(s) | AXSOME MALTA LTD. |